The LY6K transcript variant LY6K-T3 was highly expressed in HNSCC HPV+ cell lines, while LY6K transcript variants 1 and 2 were expressed in both HPV+ and HPV− cell lines. Here, LY6K is linked to head and neck squamous cell carcinoma.